Hunan Jiudian Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
April 26, 2022 at 03:22 pm IST
Share
Hunan Jiudian Pharmaceutical Co., Ltd. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was CNY 449.06 million compared to CNY 278.11 million a year ago. Revenue was CNY 449.06 million compared to CNY 278.11 million a year ago. Net income was CNY 55.97 million compared to CNY 46.45 million a year ago. Basic earnings per share from continuing operations was CNY 0.1714 compared to CNY 0.1429 a year ago. Diluted earnings per share from continuing operations was CNY 0.1714 compared to CNY 0.1429 a year ago.
Hunan Jiudian Pharmaceutical Co Ltd is a company mainly engaged in research and development, production and sales of pharmaceutical preparations. The Companyâs products are comprised of pharmaceutical preparations, raw materials, pharmaceutical excipients and plant extracts, including loxoprofen sodium gel ointment, ornidazole raw materials and preparations, dirithromycin raw materials and preparations, clindamycin phosphate tablets and so on. The products are used for the treatment of bacterial infections and anti-allergy. The Company sells its products to both domestic and international markets, including Europe, South Korea, India, Russia and South America.